No Image

Ofatumumab (Kesimpta) for MS

November 10, 2020 Auto Bot 0

Date:  December 28, 2020 Issue #:  1614 Summary:  The FDA has approved a subcutaneous formulation of the recombinant human anti-CD20 antibody ofatumumab (Kesimpta – Novartis) […]